Show More

B cell physiopathology (Virginia G. de Yebenes)

Report Abuse

Scientic Supervisor / Contact Person

Name and Surname
Virginia G. de Yebenes

Localization & Research Area

Faculty / Institute
Faculty of Medicine
Immunology, Ophthalmology and ENT
Research Area
Life Sciences (LIF)

MSCA & ERC experience

Research group / research team hosted any MSCA fellow?
Research group / research team have any ERC beneficiaries?

Research Team & Research Topic

Website of the Research team / Research Group / Department
Brief description of the Research Team / Research Group / Department
The B cell physiopathology team is part of a research ensemble recognized by the University (UCM) and validated in 2018 as excellent (91/100) by the AEI ( It joined the Hospital 12 de Octubre Health Research Institute (Area 6: Inflammatory and immune disorders). Lymphocyte Immunobiology include 10 additional groups with shared interests, facilities and weekly lab seminars. IPs (topics): Regueiro JR, Fernandez-Malave E, Recio MJ, Cardenas PP (T cell physiopathology), Martínez-Naves E/Gómez del Moral M (antigen-presenting cells and molecules), Cabañas C/Lafuente EM (cell adhesion and intracellular signalling), Reche PA (immunomedicine/epitomics), Roda-Navarro P (immune synapse and intracellular signalling), Martínez-Quiles N (signal transduction and the cytoskeleton), Goicoechea de Jorge E/Tortajada A (microRNAs and complement physiopathology), Cubero FJ (liver injury and inflammation), Redondo-Muñoz J (cell migration and epigenetics) and Iborra S (Crosstalk between Dendritic Cells and T Lymphocytes).

The B cell physiopathology team is actually composed of two predoctoral students and a master student.
Research lines / projects proposed
The main interest of the group is the characterization of the role of microRNAs in the regulation of mature B cell biology and oncogenic transformation processes. Current research lines aim at characterizing two specific aspects about the functional contribution of miRNAs to oncogenic B cell transformation to identify novel therapeutic targets for Germinal Center (GC)-derived lymphoma treatment:

1. To characterize molecular mechanisms underlying the tumor-suppressor properties of miR-28, a GC-specific miRNA whose expression is reduced in several types of primary B cell lymphomas that originate in GC B cells, including the aggressive Burkitt lymphoma (BL) and Diffuse Large B Cell Lymphoma (DLBCL).
2. To determine the impact of AID mutagenic activity on miRNA repertoire and its contribution to mature B cell transformation by promoting the escape from miRNA posttranscriptional gene expression regulation.

Application requirements

Professional Experience & Documents
Expression of interest, curriculum vitae and two recommendation letters.
You can attach the 'One Page Proposal' to enhance the attractiveness of your application. Supervisors usually appreciate it. Please take into account your background and the information provided in Research Team & Research Topic section to fill in it.

Submit an application

Click or drag files to this area to upload. You can upload up to 5 files.
Consent Management Platform by Real Cookie Banner